Ascendas REIT diversifies, Eli Lilly granted FDA emergency approval, disputes with Brazil and China, Singapore to receive early COVID-19 vaccine and Chinese regulators concerned about monopolistic behaviour

From a pop-up in London to a 10-brand international group - how do you scale in F&B without losing soul? In this episode, hosted by Michelle Martin, Chef-Founder Dave Pynt of Burnt Ends Hospitality G...

24 Feb 21min

What if the real AI opportunity in 2026 isn’t in the stocks everyone already owns? In this episode, hosted by Michelle Martin, we explore whether the crowded “AI Builder” trade is reaching diminishing...

24 Feb 19min

Is AI now a valuation divider? In this episode, hosted by Michelle Martin with Ryan Huang, we unpack UOB’s 7% dip in Q4 profit to S$1.41 billion and what it signals for Singapore banks amid a shifting...

24 Feb 18min

Is Singapore witnessing a durable capital markets revival - or the final act of a liquidity-driven surge? In this episode, hosted by Michelle Martin, we examine whether the STI’s charge past 5,000 mar...

23 Feb 16min

Markets are anything but sleepy this morning as we come to grips with US global tariff hikes to 15%. US President Donald Trump is reimposing temporary 15% tariffs after a Supreme Court setback - Mich...

23 Feb 19min

What if you could own a slice of a prime building in Singapore for the price of a holiday - and trade it like a stock? In this episode, hosted by Michelle Martin, we unpack whether real estate tokenis...

20 Feb 17min

Can you really call yourself the world’s biggest retailer if your edge comes from the cloud? In this episode, hosted by Michelle Martin with Ryan Huang, we unpack how Amazon dethroned Walmart in 2025 ...

20 Feb 23min

If AI can replace junior lawyers overnight, what does that mean for your portfolio tomorrow? In this episode, hosted by Michelle Martin, with guest Arun Pai, Associate Partner, Monk’s Hill Ventures w...

19 Feb 23min